Transforming brain health with AI-powered clinical insights

CergenX's state-of-the-art AI platform transforms complex brain activity into actionable insights. Starting with newborn brain assessments, our AI platform is redefining how neurological conditions are detected, understood and managed.

When newborn brain injury is suspected, every minute matters.

The first hours after birth are critical for identifying newborns at risk of brain injury to ensure escalation of care and timely treatment. Yet the evaluation of at-risk infants is often challenging.

6hr window to intervene

For certain brain injuries, clinicians have just hours to identify risk, escalate care and arrange transfer where needed.¹˒²

Early signs can be subtle

Early signs of brain injury can be very subtle and challenging to detect on clinical examination.³˒⁴

Insight into brain function is not available

EEG is the gold standard,³˒⁵ but timely access and expert interpretation may not be readily available.⁶˒⁷

INTRODUCING:

cergenx®

wave

Expert EEG bedside triage, in minutes.

Wave is the first and only purpose-built neonatal EEG assessment tool designed for non-specialists. In a single short assessment, it evaluates multiple clinically relevant EEG abnormalities associated with neonatal encephalopathy (NE) risk.

CE marked

FDA breakthrough device

About Wave

Re-imagining a century-old technology

For over a century, EEG has been used to provide insight into brain function. However, access remains severely limited by the need for specialist interpretation, which is not readily available in most clinical settings.

CergenX is rethinking neonatal EEG. Our state-of-the-art AI platform is expanding the clinical utility of EEG, moving it beyond specialist-dependent applications to deliver accessible bedside assessments and actionable insights to non-specialist clinicians.

Bring Wave to your hospital

Connect with our team to learn how Wave could support your service.

CE Marked, FDA clearance pending (Not for sale in the US).

Proven innovation & quality

Our network

References

Zanelli SA, et al. Therapeutic Hypothermia for Neonatal Hypoxic-Ischemic Encephalopathy: Clinical Report. Pediatrics. 2026;157(2). doi:10.1542/peds.2025-073627

Jacobs SE, Berg M, Hunt R, et al. Cooling for Newborns with Hypoxic Ischaemic Encephalopathy. Cochrane Database Syst Rev. 2013;(1). doi:10.1002/14651858.CD003311.pub3

Sandoval Karamian AG and Wusthoff CJ. Current and Future Uses of Continuous EEG in the NICU. Front Pediatr. 2021;9:768670. doi:10.3389/fped.2021.768670

Murray DM, Boylan GB, Ali I, et al. Defining the Gap Between Electrographic Seizure Burden, Clinical Expression and Staff Recognition of Neonatal Seizures. Arch Dis Child Fetal Neonatal Ed. 2008;93(3)–F191. doi:10.1136/adc.2005.086314

Wusthoff CJ, et al. The American Clinical Neurophysiology Society Guideline on Indications for Continuous Electroencephalography Monitoring in Neonates. J Clin Neurophysiol. 2025;42(1):1–11. doi:10.1097/WNP.0000000000001120

Dilena R, et al. Consensus Protocol for EEG and Amplitude-Integrated EEG Assessment and Monitoring in Neonates. Clin Neurophysiol. 2021;132(4):886–903. doi:10.1016/j.clinph.2021.01.012

Definitive Healthcare. Reports identifying US healthcare facilities performing newborn EEG. Commissioned by CergenX, 2024.